These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 23778908)
21. A challenge to integrity in spine publications: years of living dangerously with the promotion of bone growth factors. Carragee EJ; Ghanayem AJ; Weiner BK; Rothman DJ; Bono CM Spine J; 2011 Jun; 11(6):463-8. PubMed ID: 21729794 [No Abstract] [Full Text] [Related]
22. Bone Morphogenetic Proteins in Anterior Cervical Fusion: A Systematic Review and Meta-Analysis. Zadegan SA; Abedi A; Jazayeri SB; Nasiri Bonaki H; Jazayeri SB; Vaccaro AR; Rahimi-Movaghar V World Neurosurg; 2017 Aug; 104():752-787. PubMed ID: 28315798 [TBL] [Abstract][Full Text] [Related]
23. Comparison of two independent systematic reviews of trials of recombinant human bone morphogenetic protein-2 (rhBMP-2): the Yale Open Data Access Medtronic Project. Low J; Ross JS; Ritchie JD; Gross CP; Lehman R; Lin H; Fu R; Stewart LA; Krumholz HM Syst Rev; 2017 Feb; 6(1):28. PubMed ID: 28196521 [TBL] [Abstract][Full Text] [Related]
24. [Too good to be true]. Brox JI Tidsskr Nor Laegeforen; 2011 Nov; 131(22):2228-9. PubMed ID: 22085945 [No Abstract] [Full Text] [Related]
25. Ultra-low-dose recombinant human bone morphogenetic protein-2 for 3-level anterior cervical diskectomy and fusion. Pourtaheri S; Hwang K; Faloon M; Issa K; Mease SJ; Mangels D; Sinha K; Emami A Orthopedics; 2015 Apr; 38(4):241-5. PubMed ID: 25901613 [TBL] [Abstract][Full Text] [Related]
26. The Role of Bone Morphogenetic Proteins 2, 7, and 14 in Approaches for Intervertebral Disk Restoration. Belykh E; Giers M; Bardonova L; Theodore N; Preul M; Byvaltsev V World Neurosurg; 2015 Oct; 84(4):871-3. PubMed ID: 26299263 [No Abstract] [Full Text] [Related]
27. A biologic without guidelines: the YODA project and the future of bone morphogenetic protein-2 research. Carragee EJ; Baker RM; Benzel EC; Bigos SJ; Cheng I; Corbin TP; Deyo RA; Hurwitz EL; Jarvik JG; Kang JD; Lurie JD; Mroz TE; Oner FC; Peul WC; Rainville J; Ratliff JK; Rihn JA; Rothman DJ; Schoene ML; Spengler DM; Weiner BK Spine J; 2012 Oct; 12(10):877-80. PubMed ID: 23199819 [No Abstract] [Full Text] [Related]
28. Anterior lumbar interbody fusion using recombinant human bone morphogenetic protein-2: a prospective study of complications. Malham GM; Parker RM; Ellis NJ; Blecher CM; Chow FY; Claydon MH J Neurosurg Spine; 2014 Dec; 21(6):851-60. PubMed ID: 25279655 [TBL] [Abstract][Full Text] [Related]
29. A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned. Carragee EJ; Hurwitz EL; Weiner BK Spine J; 2011 Jun; 11(6):471-91. PubMed ID: 21729796 [TBL] [Abstract][Full Text] [Related]
30. Bone morphogenetic protein use in spine surgery in the United States: how have we responded to the warnings? Guzman JZ; Merrill RK; Kim JS; Overley SC; Dowdell JE; Somani S; Hecht AC; Cho SK; Qureshi SA Spine J; 2017 Sep; 17(9):1247-1254. PubMed ID: 28456674 [TBL] [Abstract][Full Text] [Related]
31. Reply to "A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned". Dimar JR; Glassman SD; Burkus JK; Pryor PW; Hardacker JW; Carreon LY Spine J; 2011 Nov; 11(11):1082-3; author reply 1083-6. PubMed ID: 22078853 [No Abstract] [Full Text] [Related]
32. Re: A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned. Woo EJ Spine J; 2011 Aug; 11(8):804; author reply 804-5. PubMed ID: 21925424 [No Abstract] [Full Text] [Related]
33. Routine use of recombinant human bone morphogenetic protein-2 in posterior fusions of the pediatric spine and incidence of cancer. Sayama C; Willsey M; Chintagumpala M; Brayton A; BriceƱo V; Ryan SL; Luerssen TG; Hwang SW; Jea A J Neurosurg Pediatr; 2015 Jul; 16(1):4-13. PubMed ID: 25860984 [TBL] [Abstract][Full Text] [Related]
34. Acknowledging the elephant in the room: conflict of interest in industry-sponsored clinical research. Hart RA Spine J; 2011 Aug; 11(8):703-4. PubMed ID: 21925414 [No Abstract] [Full Text] [Related]
35. Letter to the editor regarding "A critical review of recombinant human morphogenetic protein-2 trials in spine surgery: emerging safety concerns and lessons learned". Anderson PA Spine J; 2012 Apr; 12(4):356; author reply 356-7; discussion 357-9. PubMed ID: 22464143 [No Abstract] [Full Text] [Related]
36. Bone morphogenetic protein use in spine surgery-complications and outcomes: a systematic review. Faundez A; Tournier C; Garcia M; Aunoble S; Le Huec JC Int Orthop; 2016 Jun; 40(6):1309-19. PubMed ID: 26961193 [TBL] [Abstract][Full Text] [Related]
37. Important considerations on bone morphogenetic protein-2 and neuroinflammation. Heggeness MH Spine J; 2011 Jun; 11(6):506. PubMed ID: 21729800 [No Abstract] [Full Text] [Related]
38. Complications with the use of bone morphogenetic protein 2 (BMP-2) in spine surgery. Tannoury CA; An HS Spine J; 2014 Mar; 14(3):552-9. PubMed ID: 24412416 [TBL] [Abstract][Full Text] [Related]